Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.645 USD -2.76%
Market Cap: 779.4m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abcellera Biologics Inc
Operating Income Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Operating Income
-$237.2m
CAGR 3-Years
N/A
CAGR 5-Years
-212%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Operating Income
-CA$5.5m
CAGR 3-Years
11%
CAGR 5-Years
-24%
CAGR 10-Years
-33%
Replicel Life Sciences Inc
XTSX:RP
Operating Income
-CA$1.4m
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Operating Income
-CA$519.1k
CAGR 3-Years
N/A
CAGR 5-Years
-164%
CAGR 10-Years
2%

See Also

What is Abcellera Biologics Inc's Operating Income?
Operating Income
-237.2m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Operating Income amounts to -237.2m USD.

What is Abcellera Biologics Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-212%

Back to Top